Last update 01 Nov 2024

Nav1.8 x δ opioid receptor x Nav1.7 x NMDA receptor

Basic Info

Related Targets
Nav1.8δ opioid receptorNav1.7[+1]

Related

1
Drugs associated with Nav1.8 x δ opioid receptor x Nav1.7 x NMDA receptor
Lohocla 201
Target
NMDA receptor x Nav1.7 x Nav1.8 x δ opioid receptor
Mechanism
NMDA receptor modulators [+3]
Active Org.
Lohocla Research Corp.Lohocla Research Corp.
Originator Org.
Lohocla Research Corp.Lohocla Research Corp.
Active Indication
Chronic Pain
Inactive Indication
Anxiety Disorders
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with Nav1.8 x δ opioid receptor x Nav1.7 x NMDA receptor
NCT06243835 / RecruitingPhase 1
A Phase 1a Randomized, Double-blind, Placebo-controlled, Single Site, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Kindolor Tosylate in Healthy Adults
100 Clinical Results associated with Nav1.8 x δ opioid receptor x Nav1.7 x NMDA receptor
Login to view more data
100 Translational Medicine associated with Nav1.8 x δ opioid receptor x Nav1.7 x NMDA receptor
Login to view more data
0 Patents (Medical) associated with Nav1.8 x δ opioid receptor x Nav1.7 x NMDA receptor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free